Savara Newsroom

Savara Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 13 09:53 ET

Oppenheimer Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsNov 13 08:36 ET

Oppenheimer Keeps Their Buy Rating on Savara (SVRA)

TipRanksNov 13 08:10 ET

H.C. Wainwright Maintains Savara(SVRA.US) With Buy Rating, Cuts Target Price to $6

Moomoo NewsNov 13 07:31 ET

Evercore Downgrades Savara(SVRA.US) to Hold Rating, Cuts Target Price to $5

Moomoo NewsNov 13 07:31 ET

Savara Analyst Ratings

BenzingaNov 13 07:01 ET

Savara's Promising Molbreevi Launch: Buy Rating Backed by Strategic Initiatives and IMPALA-2 Trial Success

TipRanksNov 13 06:39 ET

Savara Downgraded to In Line From Outperform at Evercore ISI

TipRanksNov 13 06:28 ET

Piper Sandler Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsOct 10 06:31 ET

H.C. Wainwright Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsOct 8 06:33 ET

Piper Sandler Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsOct 3 16:32 ET

H.C. Wainwright Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsOct 2 06:35 ET

Evercore Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsOct 1 09:34 ET

Evercore ISI Remains a Buy on Savara (SVRA)

TipRanksOct 1 08:39 ET

Savara Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow JonesOct 1 07:12 ET

Savara Analyst Ratings

BenzingaOct 1 07:01 ET

JMP Securities Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsOct 1 01:33 ET

Oppenheimer Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsSep 30 20:32 ET

JMP Securities Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsSep 30 17:32 ET

Buy Rating Affirmed for Savara on Strong Prospects for Molgramostim in APAP Treatment

TipRanksSep 30 16:47 ET